These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1389901)

  • 61. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection.
    Draenert R; Le Gall S; Pfafferott KJ; Leslie AJ; Chetty P; Brander C; Holmes EC; Chang SC; Feeney ME; Addo MM; Ruiz L; Ramduth D; Jeena P; Altfeld M; Thomas S; Tang Y; Verrill CL; Dixon C; Prado JG; Kiepiela P; Martinez-Picado J; Walker BD; Goulder PJ
    J Exp Med; 2004 Apr; 199(7):905-15. PubMed ID: 15067030
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
    Harrer T; Harrer E; Kalams SA; Barbosa P; Trocha A; Johnson RP; Elbeik T; Feinberg MB; Buchbinder SP; Walker BD
    J Immunol; 1996 Apr; 156(7):2616-23. PubMed ID: 8786327
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Computer-based design of an HLA-haplotype and HIV-clade independent cytotoxic T-lymphocyte assay for monitoring HIV-specific immunity.
    Amicosante M; Gioia C; Montesano C; Casetti R; Topino S; D'Offizi G; Cappelli G; Ippolito G; Colizzi V; Poccia F; Pucillo LP
    Mol Med; 2002 Dec; 8(12):798-807. PubMed ID: 12606814
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antigenic oscillations and shifting immunodominance in HIV-1 infections.
    Nowak MA; May RM; Phillips RE; Rowland-Jones S; Lalloo DG; McAdam S; Klenerman P; Köppe B; Sigmund K; Bangham CR
    Nature; 1995 Jun; 375(6532):606-11. PubMed ID: 7791879
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus.
    Klenerman P; Meier UC; Phillips RE; McMichael AJ
    Eur J Immunol; 1995 Jul; 25(7):1927-31. PubMed ID: 7542596
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes.
    Langlade-Demoyen P; Michel F; Hoffenbach A; Vilmer E; Dadaglio G; Garicia-Pons F; Mayaud C; Autran B; Wain-Hobson S; Plata F
    J Immunol; 1988 Sep; 141(6):1949-57. PubMed ID: 2459197
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
    Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.
    Novitsky V; Cao H; Rybak N; Gilbert P; McLane MF; Gaolekwe S; Peter T; Thior I; Ndung'u T; Marlink R; Lee TH; Essex M
    J Virol; 2002 Oct; 76(20):10155-68. PubMed ID: 12239290
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA; Oka S; Takiguchi M
    Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
    J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HIV-specific cytotoxic T lymphocytes directed against alveolar macrophages in HIV-infected patients.
    Autran B; Plata F; Guillon JM; Joly P; Mayaud C; Debré P
    Res Virol; 1990; 141(2):131-6. PubMed ID: 2189171
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rapid characterization of HIV clade C-specific cytotoxic T lymphocyte responses in infected African children and adults.
    Goulder PJ
    Ann N Y Acad Sci; 2000 Nov; 918():330-45. PubMed ID: 11131720
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunobiology of human imunodeficiency virus infection.
    Tripathi P; Agrawal S
    Indian J Med Microbiol; 2007 Oct; 25(4):311-22. PubMed ID: 18087078
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Response to Comment on "Influence of HLA-C expression level on HIV control".
    Apps R; Carrington M
    Science; 2013 Sep; 341(6151):1175. PubMed ID: 24031003
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The choice of antigen for therapeutic immunization against AIDS.
    van Baalen CA; Stittelaar KJ; Osterhaus AD; Guillon C; Gruters RA
    Trends Immunol; 2002 Oct; 23(10):478-9. PubMed ID: 12297418
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Virus interactions with dendritic cells.
    Klagge IM; Schneider-Schaulies S
    J Gen Virol; 1999 Apr; 80 ( Pt 4)():823-833. PubMed ID: 10211949
    [No Abstract]   [Full Text] [Related]  

  • 77. Implications of HIV-specific cytotoxic T lymphocytes in AIDS.
    Plata F
    Biotherapy; 1992; 5(1):31-45. PubMed ID: 1389901
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cytotoxic T lymphocytes in HIV-induced disease: implications for therapy and vaccination.
    Plata F; Dadaglio G; Chenciner N; Hoffenbach A; Wain-Hobson S; Michel F; Langlade-Demoyen P
    Immunodefic Rev; 1989; 1(3):227-46. PubMed ID: 2698642
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women.
    Rowland-Jones S; Sutton J; Ariyoshi K; Dong T; Gotch F; McAdam S; Whitby D; Sabally S; Gallimore A; Corrah T
    Nat Med; 1995 Jan; 1(1):59-64. PubMed ID: 7584954
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
    Wagner R; Deml L; Schirmbeck R; Reimann J; Wolf H
    Behring Inst Mitt; 1994 Dec; (95):23-34. PubMed ID: 7755506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.